
Teriparatide (Zyntex) is a recombinant human parathyroid hormone (1-34) used in the treatment of osteoporosis by stimulating new bone formation and increasing bone mineral density.
Maximum bone-building efficacy provides a major advantage in geriatric medicine. Teriparatide effectively restores bone architecture in patients with severe osteoporosis or those who have failed traditional bisphosphonate therapy. This feature makes it a breakthrough treatment for postmenopausal women and men at high risk of fracture. For instance, daily subcutaneous administration triggers a rapid increase in bone mineral density (BMD) in the spine and hip. Consequently, it supports improved quality of life for aging populations. As a result, Zyntex produces Teriparatide with exceptional recombinant purity, ensuring total stability in temperature-sensitive liquid formulations.
Moreover, Zyntex provides research-grade peptides for advanced studies in mineral metabolism and fracture healing. This application allows for the study of intermittent PTH signaling on skeletal integrity. It pushes the boundaries of modern regenerative medicine. At the same time, pharmaceutical formulators value its role in developing biosimilar therapies that increase global access to bone-forming drugs. In short, our product serves as a dependable “anabolic bone agent.” It supports both the retail pharmaceutical market and specialized clinical research in orthopedics. Recently, interest in Teriparatide for dental implant osseointegration has grown, highlighting its expanding therapeutic potential.
This high-performance anabolic peptide is vital in these four specialized sectors:
It is the primary active for bone-building. Thus, it provides consistent results for treating severe vertebral bone loss.
It serves as a key agent for fracture non-union. Consequently, it helps accelerate bone healing in complex clinical cases.
It works as a key tool for PTH receptor research. Undoubtedly, it is essential for studying calcium and phosphate homeostasis.
It acts as a primary active for follow-on biologics. Specifically, it aids in formulating cost-effective metabolic bone treatments.
| Parameter | Standard Value |
|---|---|
| Product Name | Teriparatide |
| Purity (HPLC) | ≥ 99.0% |
| Molecular Formula | C181H291N55O51S2 |
| CAS Number | 52232-67-4 |
⚠️ Usage Note: Teriparatide must be stored under strict refrigeration ($2°C$ to $8°C$) and protected from light. Therefore, handle with professional care and ensure the cold chain is maintained from manufacture to clinical application to prevent bio-inactivation.